Phase III trial comparing 3-6 months of adjuvant FOLFOX4/XELOX in stage II-III colon cancer: safety and compliance in the TOSCA trial
Ann Oncol
.
2017 Dec 1;28(12):3110.
doi: 10.1093/annonc/mdx021.
Authors
S Lonardi
,
A Sobrero
,
G Rosati
,
M Di Bartolomeo
,
M Ronzoni
,
G Aprile
,
B Massida
,
M Scartozzi
,
M Banzi
,
M G Zampino
,
F Pasini
,
P Marchetti
,
M Cantore
,
A Zaniboni
,
L Rimassa
,
L Ciuffreda
,
D Ferrari
,
S Barni
,
V Zagonel
,
E Maiello
,
E Rulli
,
R Labianca
;
TOSCA (Three or Six Colon Adjuvant) Investigators
PMID:
28327986
DOI:
10.1093/annonc/mdx021
No abstract available
Publication types
Published Erratum